van der Veldt AAM - Search Results

1

[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma.

Verhoeff SR, Oosting SF, Elias SG, van Es SC, Gerritse SL, Angus L, Heskamp S, Desar IME, Menke-van der Houven van Oordt CW, van der Veldt AAM, Arens AIJ, Brouwers AH, Eisses B, Mulders PFA, Hoekstra OS, Zwezerijnen GJC, van der Graaf WTA, Aarntzen EHJG, Oyen WJG, van Herpen CML. Verhoeff SR, et al. Among authors: van der veldt aam, van der graaf wta, van herpen cml, van es sc. Clin Cancer Res. 2023 Feb 1;29(3):592-601. doi: 10.1158/1078-0432.CCR-22-0921. Clin Cancer Res. 2023. PMID: 36394882 Free PMC article.

2

[18F]fluorodeoxyglucose uptake in recurrent thyroid cancer is related to hexokinase i expression in the primary tumor.

Hooft L, van der Veldt AA, van Diest PJ, Hoekstra OS, Berkhof J, Teule GJ, Molthoff CF. Hooft L, et al. J Clin Endocrinol Metab. 2005 Jan;90(1):328-34. doi: 10.1210/jc.2004-0779. Epub 2004 Oct 27. J Clin Endocrinol Metab. 2005. PMID: 15509640

3

Microvessel density and p53 in detecting cervical cancer by FDG PET in cases of suspected recurrence.

van der Veldt AA, Hooft L, van Diest PJ, Berkhof J, Buist MR, Comans EF, Hoekstra OS, Molthoff CF. van der Veldt AA, et al. Eur J Nucl Med Mol Imaging. 2006 Dec;33(12):1408-16. doi: 10.1007/s00259-006-0108-4. Epub 2006 Jul 14. Eur J Nucl Med Mol Imaging. 2006. PMID: 16841142

4

Hexokinase III, cyclin A and galectin-3 are overexpressed in malignant follicular thyroid nodules.

Hooft L, van der Veldt AA, Hoekstra OS, Boers M, Molthoff CF, van Diest PJ. Hooft L, et al. Clin Endocrinol (Oxf). 2008 Feb;68(2):252-7. doi: 10.1111/j.1365-2265.2007.03031.x. Epub 2007 Sep 13. Clin Endocrinol (Oxf). 2008. PMID: 17868400

5

Sunitinib for treatment of advanced renal cell cancer: primary tumor response.

van der Veldt AA, Meijerink MR, van den Eertwegh AJ, Bex A, de Gast G, Haanen JB, Boven E. van der Veldt AA, et al. Clin Cancer Res. 2008 Apr 15;14(8):2431-6. doi: 10.1158/1078-0432.CCR-07-4089. Clin Cancer Res. 2008. PMID: 18413834

6

Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival.

van Cruijsen H, van der Veldt AA, Vroling L, Oosterhoff D, Broxterman HJ, Scheper RJ, Giaccone G, Haanen JB, van den Eertwegh AJ, Boven E, Hoekman K, de Gruijl TD. van Cruijsen H, et al. Clin Cancer Res. 2008 Sep 15;14(18):5884-92. doi: 10.1158/1078-0432.CCR-08-0656. Clin Cancer Res. 2008. PMID: 18794101

7

Clarifying the diagnosis of clinically suspected recurrence of cervical cancer: impact of 18F-FDG PET.

van der Veldt AA, Buist MR, van Baal MW, Comans EF, Hoekstra OS, Molthoff CF. van der Veldt AA, et al. J Nucl Med. 2008 Dec;49(12):1936-43. doi: 10.2967/jnumed.108.055046. Epub 2008 Nov 7. J Nucl Med. 2008. PMID: 18997039 Free article.

8

Genetic polymorphisms associated with a prolonged progression-free survival in patients with metastatic renal cell cancer treated with sunitinib.

van der Veldt AA, Eechoute K, Gelderblom H, Gietema J, Guchelaar HJ, van Erp NP, van den Eertwegh AJ, Haanen JB, Mathijssen RH, Wessels JA. van der Veldt AA, et al. Clin Cancer Res. 2011 Feb 1;17(3):620-9. doi: 10.1158/1078-0432.CCR-10-1828. Epub 2010 Nov 19. Clin Cancer Res. 2011. PMID: 21097692

9

Validation of serum amyloid α as an independent biomarker for progression-free and overall survival in metastatic renal cell cancer patients.

Vermaat JS, Gerritse FL, van der Veldt AA, Roessingh WM, Niers TM, Oosting SF, Sleijfer S, Roodhart JM, Beijnen JH, Schellens JH, Gietema JA, Boven E, Richel DJ, Haanen JB, Voest EE. Vermaat JS, et al. Eur Urol. 2012 Oct;62(4):685-95. doi: 10.1016/j.eururo.2012.01.020. Epub 2012 Jan 23. Eur Urol. 2012. PMID: 22285764

10

Polymorphisms in endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF) predict sunitinib-induced hypertension.

Eechoute K, van der Veldt AA, Oosting S, Kappers MH, Wessels JA, Gelderblom H, Guchelaar HJ, Reyners AK, van Herpen CM, Haanen JB, Mathijssen RH, Boven E. Eechoute K, et al. Clin Pharmacol Ther. 2012 Oct;92(4):503-10. doi: 10.1038/clpt.2012.136. Epub 2012 Sep 5. Clin Pharmacol Ther. 2012. PMID: 22948895

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters